FR2364034A1 - Nouveau vaccin inactive de virus de la rhinopneumonie equine et sa preparation - Google Patents

Nouveau vaccin inactive de virus de la rhinopneumonie equine et sa preparation

Info

Publication number
FR2364034A1
FR2364034A1 FR7726509A FR7726509A FR2364034A1 FR 2364034 A1 FR2364034 A1 FR 2364034A1 FR 7726509 A FR7726509 A FR 7726509A FR 7726509 A FR7726509 A FR 7726509A FR 2364034 A1 FR2364034 A1 FR 2364034A1
Authority
FR
France
Prior art keywords
virus
preparation
virus vaccine
equine rhinopneumonia
new inactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7726509A
Other languages
English (en)
French (fr)
Other versions
FR2364034B1 (
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky
University of Kentucky Research Foundation
Original Assignee
University of Kentucky
University of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kentucky, University of Kentucky Research Foundation filed Critical University of Kentucky
Publication of FR2364034A1 publication Critical patent/FR2364034A1/fr
Application granted granted Critical
Publication of FR2364034B1 publication Critical patent/FR2364034B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/82—Viral vaccine for equine species, e.g. horses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7726509A 1976-09-13 1977-08-31 Nouveau vaccin inactive de virus de la rhinopneumonie equine et sa preparation Granted FR2364034A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/722,817 US4083958A (en) 1976-09-13 1976-09-13 Inactivated equine rhinopneumonitis virus vaccine and use thereof

Publications (2)

Publication Number Publication Date
FR2364034A1 true FR2364034A1 (fr) 1978-04-07
FR2364034B1 FR2364034B1 ( ) 1981-06-12

Family

ID=24903513

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7726509A Granted FR2364034A1 (fr) 1976-09-13 1977-08-31 Nouveau vaccin inactive de virus de la rhinopneumonie equine et sa preparation

Country Status (4)

Country Link
US (1) US4083958A ( )
DE (1) DE2739439A1 ( )
FR (1) FR2364034A1 ( )
GB (1) GB1538704A ( )

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225582A (en) * 1979-03-08 1980-09-30 The University Of Illinois Foundation Vaccine for equine rhinopneumonitis
US4600711A (en) * 1982-08-18 1986-07-15 The University Of Kentucky Research Foundation Composition for topical and infusion treatment of wounds and burns
US4483851A (en) * 1982-08-18 1984-11-20 The University Of Kentucky Research Foundation Treatment for contagious equine metritis
US5084271B1 (en) * 1984-09-11 1997-08-05 Univ Melbourne Vaccine for equine herpesvirus
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
US6803041B2 (en) 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2003343A1 ( ) * 1968-03-06 1969-11-07 Behringwerke Ag

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2003343A1 ( ) * 1968-03-06 1969-11-07 Behringwerke Ag

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1969 *

Also Published As

Publication number Publication date
FR2364034B1 ( ) 1981-06-12
GB1538704A (en) 1979-01-24
DE2739439A1 (de) 1978-03-16
US4083958A (en) 1978-04-11
DE2739439C2 ( ) 1988-01-14

Similar Documents

Publication Publication Date Title
RU98106860A (ru) Вакцина против гриппа
SE8800731L (sv) Fenylkarbamat
DZ1067A1 (fr) Nouvelles préparations pharmaceutiques à emission prolongée.
EA199800943A1 (ru) Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы
DE3853210T2 (de) Verwendung eines viralen glykoprotein-impstoffes für intranasale immunisierung gegen eine virusinfektion.
FR2364034A1 (fr) Nouveau vaccin inactive de virus de la rhinopneumonie equine et sa preparation
NO872880L (no) FremgangsmŸte for fremstilling av difenylpropylamin-derivater.
BR1100202A (pt) Derivados de amino-2 fenil-4 tiazol, seu processo de preparação e sua aplicação terapêutica
GB1272920A (en) New thiosemicarbazides
ES336810A1 (es) Un metodo para producir una cepa de celulas.
SE7512828L (sv) Calicivirusvaccin
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
GB1192576A (en) Diagnostic Substance and Composition
ATE61522T1 (de) Pharmazeutische zubereitung zur behandlung von tinea pedis.
IT943598B (it) Processo per la preparazione di formulazioni stabili di nadh
GB1187830A (en) Pharmaceutical Compositions comprising Polynucleotides
Jungeblut Reverse Interference Between Simian and Murine Poliomyelitis Virus in Guinea Pigs.
DK299983A (da) Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse
SU575096A1 (ru) Способ стимул ции родовой де тельности
Goto et al. Experimental studies on viricidal activity of nitrogen mustard derivatives on various animal viruses
YAMAZAKI et al. Occurrence of the non-moulting tiny silkworms caused by inoculation of the flacherie (F) virus
JPS58126785A (ja) ヒトｒｎａ型腫瘍ウイルスの誘導法
JPS55111447A (en) Novel 3-amino-4-homoisotwistane derivative
BE768813A (fr) Acides aminoalkanoiques substitues, leurs sels acceptables pourl'usage pharmaceutique, leur preparation et leurs utilisations therapeutiques
FR2290220A2 (fr) Nouveau vaccin antirabique